INNOVATIVE EYEWEAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
INNOVATIVE EYEWEAR, INC. (LUCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 500 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2026-03-25
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-12-31 was 0.00 shares.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-06-30 was -9.50K shares.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2024-03-31 was 10.00K shares, a 98.46% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2024 was 500.00 shares, a 99.13% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2023 was 57.65K shares.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2021 was 1.69M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-25 | -9.50K shares derived: sum of 3 quarters · filed 2026-03-25 | 500.00 shares 10-K · filed 2026-03-25 | |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -9.50K shares derived: sum of 2 quarters · filed 2024-11-12 | 500.00 shares 10-Q · filed 2024-11-12 | -604.85K shares derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-06-30 | -9.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 500.00 shares 10-Q · filed 2024-08-12 | -604.85K shares derived: sum of 3 quarters · filed 2025-03-24 | -589.85K shares derived: sum of 4 quarters · filed 2025-03-24 | |
| 2024-03-31 | 10.00K shares 10-Q · filed 2024-05-14 | -595.35K shares derived: sum of 2 quarters · filed 2025-03-24 | -580.35K shares derived: sum of 3 quarters · filed 2025-03-24 | -580.35K shares derived: sum of 4 quarters · filed 2025-03-24 | |
| 2023-12-31 | -605.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -590.35K shares derived: sum of 2 quarters · filed 2025-03-24 | -590.35K shares derived: sum of 3 quarters · filed 2025-03-24 | 57.65K shares 10-K · filed 2025-03-24 | 1.15M shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 15.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 15.00K shares derived: sum of 2 quarters · filed 2023-11-14 | 663.00K shares 10-Q · filed 2023-11-14 | ||
| 2023-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | 648.00K shares 10-Q · filed 2023-08-11 | |||
| 2023-03-31 | 648.00K shares 10-Q · filed 2023-05-12 | ||||
| 2021-12-31 | 1.69M shares 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |